MYDA Advisors’s Neuronetics STIM Stock Holding History

MYDA Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,000	Closed	-$110K	–	201
2025 Q1	$110K	Buy	+30,000	New	+$110K	0.02%	140
2020 Q4	–	Sell	-15,000	Closed	-$73K	–	232
2020 Q3	$73K	Buy	+15,000	New	+$56.9K	0.04%	109

Other funds holding STIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

MYDA Advisors's STIM Position: Q2 2025 in Review

MYDA Advisors sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 30,000 shares — an estimated $110K sold.

MYDA Advisors first reported a position in STIM in Q3 2020 and held it in 2 quarters. The position peaked at $110K in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

MYDA Advisors reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
MYDA Advisors sold 30,000 Neuronetics shares in Q2 2025, an estimated $110K.
MYDA Advisors first reported a position in Neuronetics in Q3 2020 and held it in 2 quarters.
MYDA Advisors's Neuronetics position peaked at $110K in Q1 2025.
90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on MYDA Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.